Ethical Issues in Decision-making Regarding the Elderly Affected by Coronavirus Disease 2019: An Expert Opinion

Login or register to view PDF.
Creative Commons Licence
 
Abstract

The coronavirus disease 2019 (COVID-19) pandemic is resulting in ethical decisions regarding resource allocation. Prioritisation reflects established practices that regulate the distribution of finite resources when demand exceeds supply. However, discrimination based on sex, race or age has no role in prioritisation unless clearly justified. The risk posed by COVID-19 is higher for elderly people than for younger people, so older adults should be prioritised in preventive measures. In the case of people who already have COVID-19, healthcare professionals might prioritise those most likely to survive. Making decisions based on chronological age alone is not justified; in addition to age, other aspects that determine theoretical life expectancy must be taken into account. Individualised correct prioritisation in the allocation of scarce resources is essential to good clinical practice.

Disclosure
The authors have no conflicts of interest to declare.
Correspondence
Manuel Martinez-Sellés, Servicio de Cardiología, Hospital Gregorio Marañón, Doctor Esquerdo 46, 28007 Madrid, Spain. E: mmselles@secardiologia.es
Received date
24 April 2020
Accepted date
27 April 2020
DOI
https://doi.org/10.15420/ecr.2020.14
Open access
This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

Nearly every country is now affected by the coronavirus disease 2019 (COVID-19) pandemic. The disease is spreading rapidly and is taxing the global healthcare system, particularly intensive care units (ICUs). Physicians are faced with ethical decisions regarding the allocation of these precious resources, especially ventilators. Although only a few of those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) require admission to intensive care, the burden on healthcare systems is unprecedented. This article focuses on ethical issues in decision-making regarding COVID-19, particularly in the elderly.

Madrid has been one of the cities with the higher number of COVID-19 cases and casualties so far. We have suffered from limited resources and lived with these ethical issues on a daily basis. Also, Spain is experiencing population ageing at a rate that is unprecedented in Europe and COVID-19 infection is particularly severe in the elderly.1,2

Prioritisation

Prioritisation for the allocation of scarce resources is not confined to the COVID-19 outbreak. Transplant organs are examples of scarce resources where prioritisation criteria for allocation are common and physicians have to make a case-by-case evaluation in order to establish which patient receives the organ. Prioritisation reflects established practices that regulate the distribution of finite resources when demand happens to exceed supply. Discrimination based on sex, race or age has no role in prioritisation unless clearly justified, for example sex mismatch might influence the outcome of a heart transplant.3,4

Prioritisation does not mean that one life is more valuable than another, as all lives are equally valuable. When resources are insufficient to save all those in need, prioritisation means allocating the available assets in the most effective way. This method allows priority treatment of patients more likely to benefit from the scarce resource. Prioritisation should be as objective as possible but also flexible to changes in clinical situation. Transparent mechanisms to determine which patients will receive a specific resource are desirable and should be explained to patients who finally receive an organ, to those who are denied and to the public.

Ageism

Ageism encompasses stereotyping, prejudice and discrimination against people on the basis of their age. Ageism is widespread and an insidious practice that has harmful effects on the health of older adults. A recent systematic review showed that the significant adverse relationship between ageism and health is even more consistent than the relationships found in systematic reviews of the effects of racism on health.5 Moreover, European doctors worry about the care they will receive when they are old, with 80% of healthcare professionals anxious about how they would be treated, suggesting they realise that ageism is very common.6 Paradoxically, increasing numbers of elderly people are remaining healthy and some of them have important international responsibilities. For instance, Pope Francis is now 83 years old and Queen Elizabeth II is 94 (Figure 1).

Queen Elizabeth II and Pope Francis

Open in new tab
Open ppt

Therapeutic Planning Checklist for Elderly Patients Admitted to Hospital due to COVID-19

Open in new tab
Open ppt

COVID-19 and the Elderly

The risk posed by COVID-19 is higher for elderly people than for younger people.2 For this reason, medical and political authorities should offer older adults strict preventive measures to minimise the risk of exposure and infection. In the event that an effective vaccine for SARS-CoV-2 is developed, priority should be given to vaccination of the elderly, with the aim of maximising the number of lives saved. This is also true for other preventive measures, such as possible pre- or post-exposure prophylaxis.7

In the case of people with COVID-19, the situation is different. When allocating resources in these scenarios, healthcare professionals might prioritise those most likely to survive over those with remote chances of survival. Making a decision based on chronological age is not justified. In addition to age, other aspects that determine theoretical life expectancy must be taken into account. Biological age and the use of frailty scales and comprehensive geriatric assessment are essential for this purpose. The recent statement of the Executive Board of the European Geriatric Medicine Society insists that advanced age alone should not be a criterion for excluding patients from specialised hospital units.8 If an elderly patient is dismissed from a specialised hospital unit for any reason, access to medical attention, symptomatic treatment and palliative care must be ensured. This last point is essential, as palliative care is frequently suboptimal in elderly patients with other conditions, such as heart failure, and this is probably the case in COVID-19.2,9,10

Therapeutic Adaptation after COVID-19 Admission

In patients with advanced age who are admitted to hospital due to a severe SARS-CoV-2 infection, it is very important to establish a therapeutic adaptation plan from the time of admission. This plan should be clearly documented in the clinical history, making it clear whether or not the patient is a candidate for mechanical ventilation and, in case of their condition worsening, when to propose the withdrawal of life-sustaining therapies (Table 1). Decisions that maximise survival to hospital discharge, the number of years of life saved and the possibility of living each of the stages of life can be prioritised. In this regard, patients with minimal expected benefit should not be admitted to ICU and the admission of patients with a life expectancy <1–2 years should be carefully evaluated. This applies to patients of all ages. A utilitarian mentality should be applied, which should prevent prejudice against the elderly. For example, a frail elderly patient might have a low chance of surviving the prolonged intubation required to recover from COVID-19 pneumonia, but this is also the case for young patients with severe comorbidities.11

The Madrid Experience

During the peak of the outbreak, more than two-thirds of beds in most hospitals in Madrid were occupied by patients with COVID-19. Figure 2 depicts the official numbers of patients admitted to hospital, admitted to ICUs, who died and who recovered in Spain between mid-March and the middle of April.12 Non-invasive ventilation was attempted frequently, even using improvised alternative strategies like the modified Easybreath diving mask to administer continuous positive airway pressure therapy. Invasive ventilation was often necessary and, in spite of tremendous efforts by the hospitals (for example Gregorio Marañón University Hospital opened ICUs in operating rooms and in the library), there were not enough ICU beds for all the critically ill patients who needed them. The limited availability of ventilation support was even more problematic due to the prolonged intubation – often more than 3 weeks – that many of these patients required. The news that prioritisation criteria were being applied in Spanish hospitals sparked widespread controversy and triggered a debate about the right of every individual, particularly the elderly, to access specialised healthcare.13

Use of Off-label Therapies

Effective therapies for this novel coronavirus are needed urgently and several clinical trials are now underway.14 Meanwhile, the use of use of off-label therapies based on in vitro data and early clinical experience with COVID-19 has increased dramatically; examples include remdesivir, lopinavir, ritonavir, interferon, chloroquine, hydroxychloroquine, azithromycin, tocilizumab, steroids and cyclosporine. To date, no therapies have been shown to be effective.15 Moreover, some of these drugs have frequent and potentially life-threatening side-effects, particularly in the elderly. Most are known to prolong the QT interval and can have a proarrhythmic effect.16

Confinement: Pros and Cons

Confinement is an effective way to decrease SARS-CoV-2 transmission and is a way to win time until effective therapies are developed and/or an effective and safe vaccine is available. However, the stay-at-home policy has negative effects in those with advanced age (Figure 3). The psychological risk of confinement is particularly high among vulnerable populations, such as those in a situation of dependence or that live alone. The negative consequences are multifaceted, with physical, mental and social aspects. Staying at home for long periods of time facilitates sedentary behaviours and might worsen previous frailty or pre-frail conditions. At the time of writing this article, our parents/grandparents (aged 82 and 78) have not left their home for 2 months. We are certainly concerned about their situation. Moreover, confinement is extremely negative for the economy and the elderly might end up suffering the consequences of a severe economic depression. Finally, the legal situation varies a lot from country to country. New laws have created legal frameworks that frequently restrict or prohibit the movement of people and vehicles. Some countries have severe penalties for those who do not comply with the new rules.

Family and Mourning

The COVID-19 pandemic has isolated the elderly not only at home but also in hospitals. Visits are usually not permitted. Several patients of advanced age with severe infection have died alone in the hospital or in nursing homes.

The suffering of the family does not end there, as containment measures also apply in the context of mourning, which adds trauma to that of death itself. Corpses are considered potentially infectious, so are deposited as soon as possible in a body bag that will never be reopened. During the peak of the outbreak in Madrid, we had so many deaths that an ice rink had to be used as a provisional morgue. It was frequently impossible for families to see their deceased loved ones one last time.

Official Daily Evolution of the Number of Patients

Open in new tab
Open ppt

Confinement – the Stay-at-home Policy – has Positive

Open in new tab
Open ppt

The rules of social distancing put in place by the health authorities applies also at funerals. Services must be limited to close family members only (with a maximum of three people), usually with video recording and streaming for those who wish to attend the funeral from a distance. Finally, the vast majority of older people in Spain are Catholic. The fact that public masses have been cancelled makes the situation even more difficult for families.

Conclusion

COVID-19 in elderly patients raises some ethical issues; however, most of these issues are similar to ethical problems in other conditions, such as heart failure.17–19 The correct prioritisation for the allocation of scarce resources should be based on various factors relating to the individual. Chronological age should not be the only factor that influences the decision-making process. This is essential to good clinical practice.

References
  1. Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 2018;392:2052–90.
    Crossref | PubMed
  2. Bonanad C, García-Blas S, Tarazona-Santabalbina FJ, et al. Coronavirus: the geriatric emergency of 2020. Joint document of the Geriatric Cardiology Section of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology. Rev Esp Cardiol 2020 [in Spanish]; epub ahead of press.
    Crossref | PubMed
  3. Ayesta A, Urrútia G, Madrid E, et al. Sex-mismatch influence on survival after heart transplantation: a systematic review and meta-analysis of observational studies. Clin Transplant 2019;33:e13737.
    Crossref | PubMed
  4. Martinez-Selles M, Almenar L, Paniagua-Martin MJ, et al. Donor/recipient sex mismatch and survival after heart transplantation: only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry. Transpl Int 2015;28:305–13.
    Crossref | PubMed
  5. Chang ES, Kannoth S, Levy S, et al. Global reach of ageism on older persons’ health: a systematic review. PLoS One 2020;15:e0220857.
    Crossref | PubMed
  6. Torjesen I. European doctors worry about the care they will receive when they are old. BMJ 2012;344:e77.
    Crossref | PubMed
  7. Emanuel EJ, Persad G, Upshur R, et al. Fair allocation of scarce medical resources in the time of COVID-19. N Engl J Med 2020; epub ahead of press.
    Crossref | PubMed
  8. European Geriatric Medicine. Statement of the EuGMS Executive Board on the COVID-19 epidemic. 2020. www.eugms.org/news/read/article/489.html (accessed 5 May 2020).
  9. García Pinilla JM, Díez-Villanueva P, Bover Freire R, et al. Consensus document and recommendations on palliative care in heart failure of the Heart Failure and Geriatric Cardiology Working Groups of the Spanish Society of Cardiology. Rev Esp Cardiol 2020;73:69–77.
    Crossref | PubMed
  10. Sobanski PZ, Alt-Epping B, Currow DC, et al. Palliative care for people living with heart failure: European Association for Palliative Care Task Force expert position statement. Cardiovasc Res 2020;116:12–27.
    Crossref | PubMed
  11. Rosenbaum L. Facing Covid-19 in Italy – ethics, logistics, and therapeutics on the epidemic’s front line. N Engl J Med 2020; epub ahead of press.
    Crossref | PubMed
  12. Ministerio de Sanidad. Daily evolution of COVID-19 in Spain. 2020. https://covid19.isciii.es/resources/CURVASTATUS.png (accessed 5 May 2020)" target="_blank">PubMed
  13. Grupo de Trabajo de Bioética de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC). Recomendaciones éticas para la toma de decisiones en la situación excepcional de crisis por pandemia COVID-19 en las unidades de cuidados intensivos. 2020. https://semicyuc.org/wp-content/uploads/2020/03/%C3%89tica_SEMICYUC-COVI... (accessed 5 May 2020).
  14. Alpern JD, Gertner E. Off-label therapies for COVID-19. Are we all in this together? Clin Pharmacol Ther 2020; epub ahead of press.
    Crossref | PubMed
  15. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA 2020; epub ahead of press.
    Crossref | PubMed
  16. Kochi AN, Tagliari AP, Forleo GB, et al. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol 2020; epub ahead of press.
    Crossref | PubMed
  17. Charlier P. Covid-19 and some ethical issues in France. Ethics Med Public Health 2020:100510 [in French]; epub ahead of press.
    Crossref | PubMed
  18. Mannelli C. Whose life to save? Scarce resources allocation in the COVID-19 outbreak. J Med Ethics 2020; epub ahead of press.
    Crossref | PubMed
  19. Martínez-Sélles M, Díez Villanueva P, Smeding R, et al. Reflections on ethical issues in palliative care for patients with heart failure. European Journal of Palliative Care 2017;24:18–22.